Press "Enter" to skip to content

New patent expiration for Glaxo Grp drug FLOVENT HFA

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxo Grp drug FLOVENT HFA

Annual Drug Patent Expirations for FLOVENT+HFA
Annual Drug Patent Expirations for FLOVENT+HFA

Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug.

FLOVENT HFA drug price trends.

Drug patent litigation for FLOVENT HFA.

This drug has thirty patent family members in fourteen countries.

The generic ingredient in FLOVENT HFA is fluticasone propionate. Three suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxo Grp drug FLOVENT HFA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!